EP300/CBP ligand 2
EP300/CBP ligand 2 (compound S19) is a ligand targeting the bromodomain of CREB binding protein (CBP) and E1A-associated protein (EP300). EP300/CBP ligand 2 can be used as a target protein ligand in the PROTAC structure, and can be coupled to the E3 ubiquitin ligase ligand through the PTOTAC Linker to synthesize PROTAC molecules with degradation effects. For example, EP300/CBP ligand 2 can be coupled with the conjugate (E3 ubiquitin enzyme ligand + Linker) Thalidomide-NH-C10-Boc to produce the PROTAC molecule dCE-2 (HY-161958).
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain; Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ep300-cbp-ligand-2.html
Smiles
NC1=CC(C2=NN(C)C=C2)=CC(C(NC3=CC=CC4=C3C=C(C)N=N4)=O)=C1
Molecular Formula
C20H18N6O
Molecular Weight
358.40
References & Citations
[1]Structure-Based Design of CBP/EP300 Degraders: When Cooperativity Overcomes Affinity
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog